E-DRUG: Cancer (and other) drug development
-------------------------------------------
The information below may not be strictly relevant, but I think e-druggers
may find it interesting. It came from a US Marketing Magazine
(illuminating, if eccentric, reference sources for those seeking to
understand the industry). Note the amount of products for cancer. The
article did not go into any more detailed breakdown of cancer types
targeted.
All the best
David Gilbert
Fellow, Office for Public Management
252b Gray's Inn Road
London, WC1X 8JT
Tel: 0171 837 9600
Fax: 0171 837 7364
EMail dgilbert@opm.co.uk
Baby-boomer products:
(1) Projected sales of medications in development for older Americans
(2) Number of medications in development for older Americans
Group (1) Projected sales (2) No. in development
Alzheimer's disease therapies $2 billion by 2000 38
Antiarthritic agents $1.5 billion by 2004 68
Bone metabolism regulators $5.7 billion by 2000 60
Cancer treatments $8.4 billion by 2002 694
Cardiovascular drugs $56.6 billion by 2003 206
Cholesterol reducers $7.45 billion by 2005 18
Dermatological products $1.46 billion by 2006 128
Diabetes treatments $4 billion by 2005 90
Respiratory therapies $9 billion by 2007 147
Stroke treatments $1.2 billion by 2007 51
Source: Med Ad News. Dec. 1998.
[Is that journal available on the Internet? WB]
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.